Dr. Reddy's Laboratories gets EIR for Andhra Pradesh’s manufacturing facility

06 Mar 2026 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the United States Food & Drug Administration (USFDA) for its formulations manufacturing facility (FTO-SEZ PU01) in Srikakulam, Andhra Pradesh. The USFDA has classified the inspection outcome as Voluntary Action Indicated (VAI) and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Earlier, the USFDA had conducted GMP and a Pre-Approval Inspection (PAI) at the said facility from December 4 to December 12, 2025, and issued a Form 483 with 5 observations.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1254.65 -27.30 (-2.13%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×